{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMPIG6B encodes an inhibitory immunoreceptor of the immunoglobulin superfamily that is predominantly expressed on platelets and megakaryocytes. Its extracellular domain, which can bind heparin with high affinity, and its intracellular region, containing immunoreceptor tyrosine‐based inhibitory motifs (ITIMs), enable it to recruit tyrosine phosphatases such as SHP‑1 and SHP‑2. Together, these features allow MPIG6B to dampen activation signals and to thereby control platelet aggregation and activation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its role in directly inhibiting platelet activation, MPIG6B contributes to the regulation of constitutive signaling pathways mediated by Src and Syk kinases. Its extracellular binding to glycosaminoglycan chains, for instance those on heparan sulfate proteoglycans like perlecan, further modulates its inhibitory function. Intriguingly, MPIG6B’s expression is also controlled in immune cells where it may be upregulated—for example, via IL‑4-dependent STAT6 activation—hinting at a broader immunoregulatory role."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nClinically, loss‐of‐function mutations in MPIG6B have been linked to congenital macrothrombocytopenia accompanied by bone marrow fibrosis, splenomegaly, and abnormal platelet function. Genetic studies in both human patients and mouse models have underscored the pivotal role of MPIG6B in maintaining platelet production and homeostasis. Furthermore, its potential as an immunotherapy target in conditions such as myelofibrosis emphasizes the translational impact of understanding its signaling mechanisms."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "5", "end_ref": "8"}]}, {"type": "t", "text": ""}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Edwin C J M de Vet, Stephen A B Newland, Paul A Lyons, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The cell surface receptor G6b, a member of the immunoglobulin superfamily, binds heparin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2005.03.032"}], "href": "https://doi.org/10.1016/j.febslet.2005.03.032"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15848171"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15848171"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Stephen A Newland, Iain C Macaulay, Andres R Floto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The novel inhibitory receptor G6B is expressed on the surface of platelets and attenuates platelet function in vitro."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2006-09-047449"}], "href": "https://doi.org/10.1182/blood-2006-09-047449"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17311996"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17311996"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Jianfeng Li, Martin Cadeiras, Manuel Prinz von Bayern, et al. "}, {"type": "b", "children": [{"type": "t", "text": "G6b-B cell surface inhibitory receptor expression is highly restricted to CD4+ T-cells and induced by interleukin-4-activated STAT6 pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Immunol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.humimm.2007.04.008"}], "href": "https://doi.org/10.1016/j.humimm.2007.04.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17678728"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17678728"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Jun Mori, Andrew C Pearce, Jennifer C Spalton, et al. "}, {"type": "b", "children": [{"type": "t", "text": "G6b-B inhibits constitutive and agonist-induced signaling by glycoprotein VI and CLEC-2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M806895200"}], "href": "https://doi.org/10.1074/jbc.M806895200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18955485"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18955485"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Inga Hofmann, Mitchell J Geer, Timo Vögtle, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Congenital macrothrombocytopenia with focal myelofibrosis due to mutations in human G6b-B is rescued in humanized mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2017-08-802769"}], "href": "https://doi.org/10.1182/blood-2017-08-802769"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29898956"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29898956"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Hui Chen, Jie Zheng, Zhenping Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Case report of a novel MPIG6B gene mutation in a Chinese boy with pancytopenia and splenomegaly."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2019.143957"}], "href": "https://doi.org/10.1016/j.gene.2019.143957"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31276734"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31276734"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Timo Vögtle, Sumana Sharma, Jun Mori, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Heparan sulfates are critical regulators of the inhibitory megakaryocyte-platelet receptor G6b-B."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Elife (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7554/eLife.46840"}], "href": "https://doi.org/10.7554/eLife.46840"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31436532"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31436532"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Bethan Psaila, Guanlin Wang, Alba Rodriguez-Meira, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Single-Cell Analyses Reveal Megakaryocyte-Biased Hematopoiesis in Myelofibrosis and Identify Mutant Clone-Specific Targets."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2020.04.008"}], "href": "https://doi.org/10.1016/j.molcel.2020.04.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32386542"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32386542"}]}]}]}